Factors Affecting the Pharmacology of Antibody–Drug Conjugates

Major advances in therapeutic proteins, including antibody–drug conjugates (ADCs), have created revolutionary drug delivery systems in cancer over the past decade. While these immunoconjugate agents provide several advantages compared to their small-molecule counterparts, their clinical use is still...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucas, Andrew T., Price, Lauren S. L., Schorzman, Allison N., Storrie, Mallory, Piscitelli, Joseph A., Razo, Juan, Zamboni, William C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698819/
https://www.ncbi.nlm.nih.gov/pubmed/31544862
http://dx.doi.org/10.3390/antib7010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698819/
https://www.ncbi.nlm.nih.gov/pubmed/31544862
http://dx.doi.org/10.3390/antib7010010

Ejemplares similares